Anchor
ANCHOR NA Purification System (new/coming soon) for automated, high-speed nucleic acid extraction upstream of PCR. Quant/Qual capability for DNA targets: CMV, EBV, HSV-1/2, VZV, HHV-6/7/8, BK/JC (coming soon). Differentiation built in for many kits (HSV-1 vs 2; Influenza A vs B; Norovirus GI vs GII; Monkeypox vs other Orthopox; BK vs JC; multi-analyte respiratory panels). Multiplex options for higher efficiency: HHV-6/7/8; Viral Respiratory Multiplex; Inf A/B + SARS-2. Regulatory coverage: broad CE-IVD offering for routine diagnostics plus RUO panels for research and surveillance. Scalable throughput: standard 100-reaction kits and 384-reaction formats for high-volume labs. Please Log In to access Additional Details and documents … Herpesvirus DNA (CE-IVD single-plex): CMV, EBV, HSV-1/2 (diff.), VZV — quant/qual detection suitable for monitoring and diagnostics. Herpesvirus DNA (RUO multiplex): HHV-6/7/8 — quant/qual with three-target differentiation for research workflows. Respiratory RNA (qualitative): CE-IVD: Influenza A/B single panel; SARS-CoV-2 v2.0 (384) for high-throughput testing. RUO: Viral Respiratory Multiplex (Flu A, Flu B, RSV, SARS-CoV-2) and Inf A/B + SARS-2 (384) for broader research screening. Gastrointestinal & bacterial: Norovirus (GI vs GII, CE-IVD, qualitative RNA) and C. difficile toxins A/B (CE-IVD, qualitative DNA).Featured kits
Emerging/other DNA viruses (RUO): Monkeypox/Orthopox differentiation; BK/JC (coming soon) for polyomavirus research.
